Market Vectors® Biotech ETF (BBH)

Delayed Data
As of Feb 27
 -1.22 / -0.94%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors ® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for Market Vectors® Biotech ETF.


1 month+2.83% 3 years+45.04%
3 months+10.56% 5 years--
1 year+23.44% Since inception+50.42%
Data through 02/27/2015

Quote Details

Previous close$129.20
Open day’s range127.47 – 129.30
Net asset value (NAV)129.14 (02/26/2015)
Daily volume133,086
Average volume (3 months)164,150
Data as of 3:59pm ET, 02/27/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return--+22.29%
Expense Gross exp ratio0.41%0.47%
Risk 5 year sharpe ratio--1.47
Net assets$725.9M$1.6B
Average market cap$31.0B$35.3B
Average P/E32.226.2
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences13.93%
AMGN Amgen11.23%
CELG Celgene10.69%
BIIB Biogen7.87%
BMRN Biomarin Pharmaceutical Inc4.62%
ALXN Alexion Pharmaceuticals Inc4.62%
ILMN Illumina Inc4.61%
REGN Regeneron Pharmaceuticals4.28%
INCY Incyte Corp4.16%
VRTX Vertex Pharmaceuticals Inc4.09%

To view my watchlist

Not a member yet?

Sign up now for a free account